Comparison of Treatment Alternatives for Myofascial Pain Causing Central Sensitization
Myofascialpain
Comparison of the Effects of Stabilization Splint and Muscle Exercises on Pain and Muscle Thickness in Patients With Central Sensitization Caused by Myofascial Pain: A Randomized Controlled Clinical Trial
1 other identifier
interventional
80
1 country
1
Brief Summary
Myofascial pain is a regional muscle pain condition characterized by hard local areas and tender bands, known for the presence of trigger points in muscle tissue. The treatment is to eliminate the etiologic factor. Regular exercise is recommended to relieve the trigger points. Occlusal splints, considered the gold standard in the treatment of temporomandibular joint disorders, are used to manage and control symptoms. In this study, patients between the ages of 18-45 years who applied to Çukurova University Faculty of Dentistry, Department of Prosthodontics with the complaint of myofascial pain and scored above 40 on the central sensitization scale will be taken as a sample.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started May 2025
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
March 5, 2025
CompletedFirst Posted
Study publicly available on registry
March 11, 2025
CompletedStudy Start
First participant enrolled
May 12, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 1, 2026
CompletedStudy Completion
Last participant's last visit for all outcomes
May 25, 2026
ExpectedMay 18, 2025
March 1, 2025
12 months
March 5, 2025
May 14, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Muscle Thickness
Bilateral masseter and temporal muscle thicknesses of the participants will be measured with an ultrasound device (Clarius L7, Vancouver, Canada) , muscle thickness differences will be evaluated and the time period in which the effectiveness of the treatments will be observed will be determined.
Baseline, 2 weeks, 4 weeks, 8 weeks, 12 weeks
Secondary Outcomes (1)
Graded chronic pain scale
Baseline, 4 weeks, 8 weeks, 12 weeks
Study Arms (4)
Control group
NO INTERVENTIONParticipants were trained on the protection program.
Stabilization splint group
ACTIVE COMPARATORThe participants will use occlusal splints that are digitally designed by transferring the measurements taken with intraoral scans (TRIOS5, 3Shape TRIOS A/S, Copenhagen, Denmark) to the exocad design program and produced by three-dimensional printers.
Exercises Group
ACTIVE COMPARATORParticipants will be given home-based exercise programs prepared by physical therapists.
Stabilization Splint and Exercises Group
ACTIVE COMPARATORParticipants will use occlusal splints, which are digitally designed by transferring the measurements taken with intraoral scans (TRIOS5, 3Shape TRIOS A/S, Copenhagen, Denmark) to the exocad design program and produced from 3D printers, and home exercise programs prepared by physical therapists will be given.
Interventions
Measurements will be taken from the patients with intraoral scans, transferred to the design program and a stabilization splint will be digitally designed. The designed splint will be produced from 3D printers.
Muscle exercises prepared by physical therapists will be planned to relieve trigger points in the masticatory muscles.
Eligibility Criteria
You may qualify if:
- Examination of bilateral masseter and temporal muscles for the presence of trigger points
- Score above 40 on the CSI scale
You may not qualify if:
- Noise during jaw movements (click, crepitation)
- Presence of systemic diseases involving joints (rheumatoid arthritis)
- Having received treatment for joint discomfort in the last six months (botox, splinting, exercise, counseling)
- Use of drugs affecting the central system (gabapentin, pregabalin, tricyclic antidepressants)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Çukurova Üniversitesi Diş Hekimliği Fakültesi Protetik Diş Tedavisi Anabilim Dalı
Sarıçam, Balcalı Mahallesi, 01250, Turkey (Türkiye)
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- CARE PROVIDER, OUTCOMES ASSESSOR
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- SEQUENTIAL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Arş. Gör. Dt.
Study Record Dates
First Submitted
March 5, 2025
First Posted
March 11, 2025
Study Start
May 12, 2025
Primary Completion
May 1, 2026
Study Completion (Estimated)
May 25, 2026
Last Updated
May 18, 2025
Record last verified: 2025-03
Data Sharing
- IPD Sharing
- Will share